Skip to main content

Dupilumab Injection Shortage

Last Updated: May 7, 2025
Status: Current

Products Affected - Description
    • Dupixent subcutaneous solution for injection, Sanofi-Aventis, 200 mg, 1.14 mL pen injector, 2 count, NDC 00024-5919-02
    • Dupixent subcutaneous solution for injection, Sanofi-Aventis, 200 mg, 1.14 mL prefilled syringe, 2 count, NDC 00024-5918-01
    • Dupixent subcutaneous solution for injection, Sanofi-Aventis, 300 mg, 2 mL pen injector, 2 count, NDC 00024-5915-02
    • Dupixent subcutaneous solution for injection, Sanofi-Aventis, 300 mg, 2 mL prefilled syringe, 2 count, NDC 00024-5914-01
Reason for the Shortage
    • Sanofi did not provide a reason for the shortage of Dupixent.
Available Products
    • There is insufficient supply for usual ordering

Estimated Resupply Dates

    • Sanofi has all Dupixent presentations on allocation.

Updated

Created May 7, 2025 by Leslie Jensen, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.